Callan Family Office’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Buy
7,088
+1,382
+24% +$650K 0.06% 275
2026
Q1
$2.26M Buy
5,706
+354
+7% +$160K 0.05% 321
2025
Q4
$2.51M Buy
5,352
+1,671
+45% +$742K 0.05% 310
2025
Q3
$1.82M Buy
3,681
+171
+5% +$96.7K 0.06% 277
2025
Q2
$1.8M Buy
3,510
+1,942
+124% +$905K 0.06% 287
2025
Q1
$672K Sell
1,568
-998
-39% -$485K 0.05% 272
2024
Q4
$1.25M Buy
+2,566
New +$1.34M 0.08% 210

Other funds holding SNPS

Callan Family Office's SNPS Position: Q2 2026 in Review

Callan Family Office increased its Synopsys (SNPS) stake by 24% in Q2 2026, buying an estimated $650K and bringing the position to 7,088 shares worth $3.16M. The position accounts for 0.06% of the portfolio, ranked #275.

Callan Family Office first reported a position in SNPS in Q4 2024 and has held it in 7 quarters since. 1,450 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Callan Family Office held 7,088 shares of Synopsys worth $3.16M as of Q2 2026.
  • Callan Family Office bought 1,382 Synopsys shares in Q2 2026, an estimated $650K.
  • Synopsys made up 0.06% of Callan Family Office's portfolio in Q2 2026, its #275 holding.
  • Callan Family Office first reported a position in Synopsys in Q4 2024 and has held it in 7 quarters since.
  • 1,450 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.